Detailed View
TEVA - Teva Pharmaceutical Industries
Latest filing: 2026-06-30 | Reporting: gaap
Market Cap
48,360,325,120
Adj EBIT (TTM)
4,120,000,000
Enterprise Value
49,209,325,120
Last Price
41.47
Earnings Yield
8.37%
Return on Capital
83.65%
Capital
4,925,000,000
1Y Price Chart
Last Price: $41.47
1Y Change: 109.63%
As of 2026-10-29 | 1Y Change: 109.63%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-06-30 | 10-Q | 2026 | 4,142,000,000 | 562,000,000 |
| 2026-03-31 | 10-Q | 2026 | 3,982,000,000 | 652,000,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 4,711,000,000 | 1,856,000,000 |
| 2025-09-30 | 10-Q | 2025 | 4,480,000,000 | 882,000,000 |
| 2025-06-30 | 10-Q | 2025 | 4,176,000,000 | 1,255,000,000 |
| 2025-03-31 | 10-Q | 2025 | 3,891,000,000 | 1,333,000,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 4,229,000,000 | 1,335,000,000 |
| 2024-09-30 | 10-Q | 2024 | 4,332,000,000 | 1,050,000,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.